Clearstead Advisors’s Option Care Health OPCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$206K Sell
7,653
-6,102
-44% -$198K ﹤0.01% 989
2025
Q4
$438K Buy
13,755
+4,165
+43% +$122K 0.01% 693
2025
Q3
$266K Sell
9,590
-305
-3% -$8.83K ﹤0.01% 810
2025
Q2
$321K Buy
9,895
+1,663
+20% +$53.7K ﹤0.01% 741
2025
Q1
$288K Buy
8,232
+468
+6% +$14.7K ﹤0.01% 726
2024
Q4
$180K Sell
7,764
-3,160
-29% -$79.9K ﹤0.01% 885
2024
Q3
$342K Sell
10,924
-261
-2% -$8.01K 0.01% 676
2024
Q2
$310K Buy
11,185
+1,065
+11% +$31.7K 0.01% 668
2024
Q1
$305K Buy
10,120
+545
+6% +$17.6K 0.02% 399
2023
Q4
$323K Sell
9,575
-9,115
-49% -$280K 0.02% 383
2023
Q3
$605K Buy
18,690
+8,995
+93% +$303K 0.02% 376
2023
Q2
$315K Buy
+9,695
New +$292K 0.02% 362

Other funds holding OPCH

Clearstead Advisors's OPCH Position: Q1 2026 in Review

Clearstead Advisors reduced its Option Care Health (OPCH) stake by 44% in Q1 2026, selling an estimated $198K and leaving 7,653 shares worth $206K. The position accounts for ﹤0.01% of the portfolio, ranked #989.

Clearstead Advisors first reported a position in OPCH in Q2 2023 and has held it in 12 quarters since. The position peaked at $605K in Q3 2023. 369 funds tracked by Wall St. Rank hold OPCH as of Q1 2026.

  • Clearstead Advisors held 7,653 shares of Option Care Health worth $206K as of Q1 2026.
  • Clearstead Advisors sold 6,102 Option Care Health shares in Q1 2026, an estimated $198K.
  • Option Care Health made up ﹤0.01% of Clearstead Advisors's portfolio in Q1 2026, its #989 holding.
  • Clearstead Advisors first reported a position in Option Care Health in Q2 2023 and has held it in 12 quarters since.
  • Clearstead Advisors's Option Care Health position peaked at $605K in Q3 2023.
  • 369 funds tracked by Wall St. Rank held Option Care Health as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.